Skip to main content
Home
Search
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
Search General Info
Search Education
Search Partnering Companies
×
×
Search General Info
Search
×
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
BIO Digital
Speakers & Presenters
Meet the experts speaking on our world-class education program.
June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
General Info
Education
Partnering Companies
×
Search General Info
Search
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
2020 BIO Digital Thought Leaders
All Speakers
Search
Filter
Session Types & Networking
Focus Areas
Interests
Company Presentations
Reset
Apply Filter
×
By Count
|
Alphabetical
Company Presentations
(341)
On Demand Sessions
(303)
Interactive Sessions
(124)
Interactive Super Sessions
(41)
Interactive Special Programs
(29)
Start-Up Stadium
(27)
Global Innovation Hubs
(24)
Interactive Plenaries
(22)
On Demand Special Programs
(17)
Interactive Fireside Chat
(10)
BioProcess International Theater
(5)
Show All
×
By Count
|
Alphabetical
COVID-19
(93)
Business Development and Finance
(51)
Digital Health
(46)
Oncology
(38)
Orphan and Rare Diseases
(34)
Infectious Disease and Vaccines
(32)
Value‚ Patient Access and Reimbursement
(28)
Brain Health
(27)
Personalized Medicine and Diagnostics
(26)
Next Generation Biotherapeutics
(23)
Emerging Opportunities in Global Markets
(21)
Cell & Gene Therapies and Genome Editing
(21)
Patient Advocacy
(17)
Highly Prevalent Chronic Diseases
(15)
Intellectual Property
(13)
Translational Research
(9)
Workforce Development
(9)
Emerging Therapies
(5)
Emerging Techniques, Technologies and Strategies
(1)
Show All
×
By Count
|
Alphabetical
Therapeutics
(126)
Oncology
(99)
COVID-19
(90)
Personalized Medicine
(81)
Preclinical/Research
(81)
Biologics
(76)
Business Development
(76)
CNS/Neurological
(73)
Small Molecules
(70)
Immunology
(69)
Gene/Cell Therapy
(64)
Infectious Diseases
(61)
Diagnostics
(60)
Genomics
(60)
Neurological Disease
(57)
Drug Delivery
(55)
Digital Health
(52)
Medical Devices
(47)
Cell Biology
(44)
Inflammatory Disease
(43)
Screening
(42)
Biomanufacturing
(41)
Translational Research
(41)
Vaccines
(40)
Regulatory Innovation
(40)
Molecular Diagnostics
(39)
Bioinformatics
(39)
Regenerative Medicine
(38)
Metabolic Diseases
(37)
Genetic Disorders
(35)
Intellectual Property
(35)
Contract Research
(34)
Cardiovascular
(33)
Research Tools
(32)
Autoimmune Disease
(31)
Immune Disorder
(31)
Brain Health
(30)
Stem Cell Research
(29)
Gastroenterology
(28)
Musculoskeletal
(26)
Hematology
(25)
Contract Manufacturing
(25)
Proteomics
(25)
Ophthalmology
(25)
Tissue Engineering
(25)
Respiratory
(24)
Transplant Medicine
(22)
Degeneration
(21)
Endocrinology
(20)
Pain Management
(20)
Gene Editing
(20)
Mental Health
(20)
Biobased Products
(19)
Renal
(19)
Nanotechnology
(18)
Urology
(17)
Workforce Development
(17)
Functional Genetics
(17)
Biodefense
(16)
Regulatory Science
(15)
Opioids
(15)
Pulmonary
(15)
Pharmacogenomics
(14)
Psychiatric
(14)
Reproductive Medicine
(13)
Dermatology
(13)
Imaging
(12)
Genitourinary
(12)
Transgenics
(12)
Genetically-enhanced Microbes
(12)
Ocuylar
(11)
One Health
(11)
Prophylaxis
(11)
Diversity
(10)
Nutraceuticals
(10)
Chemicals
(9)
Gynecology and obstetrics
(9)
Plant-made Pharmaceuticals
(8)
Biocatalysis
(8)
Multiline Global Biopharma
(8)
Bio-Energy
(7)
Nutritional Disorder
(7)
Aquaculture
(7)
Animal-made Pharmaceuticals
(7)
Toxicity and Intoxication
(6)
Micro Arrays
(6)
Personal Care
(6)
Growth Disorder
(5)
Industrial Chemicals
(5)
Industrial Enzymes
(5)
Microfluidics
(5)
Food Additives
(4)
Show All
×
Company Type
Privately Funded Company
(230)
Publicly Traded Company
(80)
Advocacy/Non-Profit/Other
(29)
Show All
Main Therapeutic Focus
Oncology
(67)
CNS/Neurological
(34)
Other
(31)
Multiple Therapeutics
(30)
Platform for Therapeutics
(19)
Tools/Drug Development Support Tech
(17)
Gene/Cell Therapy
(15)
Contract Research Organization
(12)
Infectious Diseases
(11)
Digital Health
(11)
Orphan/Rare Diseases
(9)
Contract Manufacturing Organization
(9)
Regenerative Medicine
(8)
Metabolic Diseases
(8)
Ophthalmology
(7)
Diagnostics
(6)
Gastrointestinal
(5)
Inflammation
(5)
Medical Devices
(5)
Dermatology
(4)
Immunology
(4)
Multiline Global Biopharma
(4)
Non-Profit/Patient Advocacy Group
(4)
Cardiovascular
(4)
Pain Management
(3)
COVID-19
(2)
Industrial & Environmental
(2)
Reproductive/Sexual Health
(2)
Respiratory
(2)
Food & Agriculture
(1)
Renewable Chemicals
(1)
Show All
Development Phase of Primary Product
Pre-Clinical
(92)
Other/Not Applicable
(67)
Phase I
(33)
Phase II
(33)
Multiple Products in Market
(33)
Phase III
(28)
Discovery
(13)
NDA Preparation / In Review
(9)
Phase IV
(1)
Show All
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
All Speakers
Search
Filter
Filter by letter
Please Select ...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
×
Filter Speakers
Session Types & Networking
Please Select ...
Company Presentations (341)
On Demand Sessions (303)
Interactive Sessions (124)
Interactive Super Sessions (41)
Interactive Special Programs (29)
Start-Up Stadium (27)
Global Innovation Hubs (24)
Interactive Plenaries (22)
On Demand Special Programs (17)
Interactive Fireside Chat (10)
BioProcess International Theater (5)
Focus Areas
Please Select ...
COVID-19 (93)
Business Development and Finance (51)
Digital Health (46)
Oncology (38)
Orphan and Rare Diseases (34)
Infectious Disease and Vaccines (32)
Value‚ Patient Access and Reimbursement (28)
Brain Health (27)
Personalized Medicine and Diagnostics (26)
Next Generation Biotherapeutics (23)
Emerging Opportunities in Global Markets (21)
Cell & Gene Therapies and Genome Editing (21)
Patient Advocacy (17)
Highly Prevalent Chronic Diseases (15)
Intellectual Property (13)
Translational Research (9)
Workforce Development (9)
Emerging Therapies (5)
Emerging Techniques, Technologies and Strategies (1)
Interests
Please Select ...
Therapeutics (126)
Oncology (99)
COVID-19 (90)
Personalized Medicine (81)
Preclinical/Research (81)
Biologics (76)
Business Development (76)
CNS/Neurological (73)
Small Molecules (70)
Immunology (69)
Gene/Cell Therapy (64)
Infectious Diseases (61)
Diagnostics (60)
Genomics (60)
Neurological Disease (57)
Drug Delivery (55)
Digital Health (52)
Medical Devices (47)
Cell Biology (44)
Inflammatory Disease (43)
Screening (42)
Biomanufacturing (41)
Translational Research (41)
Vaccines (40)
Regulatory Innovation (40)
Molecular Diagnostics (39)
Bioinformatics (39)
Regenerative Medicine (38)
Metabolic Diseases (37)
Genetic Disorders (35)
Intellectual Property (35)
Contract Research (34)
Cardiovascular (33)
Research Tools (32)
Autoimmune Disease (31)
Immune Disorder (31)
Brain Health (30)
Stem Cell Research (29)
Gastroenterology (28)
Musculoskeletal (26)
Hematology (25)
Contract Manufacturing (25)
Proteomics (25)
Ophthalmology (25)
Tissue Engineering (25)
Respiratory (24)
Transplant Medicine (22)
Degeneration (21)
Endocrinology (20)
Pain Management (20)
Gene Editing (20)
Mental Health (20)
Biobased Products (19)
Renal (19)
Nanotechnology (18)
Urology (17)
Workforce Development (17)
Functional Genetics (17)
Biodefense (16)
Regulatory Science (15)
Opioids (15)
Pulmonary (15)
Pharmacogenomics (14)
Psychiatric (14)
Reproductive Medicine (13)
Dermatology (13)
Imaging (12)
Genitourinary (12)
Transgenics (12)
Genetically-enhanced Microbes (12)
Ocuylar (11)
One Health (11)
Prophylaxis (11)
Diversity (10)
Nutraceuticals (10)
Chemicals (9)
Gynecology and obstetrics (9)
Plant-made Pharmaceuticals (8)
Biocatalysis (8)
Multiline Global Biopharma (8)
Bio-Energy (7)
Nutritional Disorder (7)
Aquaculture (7)
Animal-made Pharmaceuticals (7)
Toxicity and Intoxication (6)
Micro Arrays (6)
Personal Care (6)
Growth Disorder (5)
Industrial Chemicals (5)
Industrial Enzymes (5)
Microfluidics (5)
Food Additives (4)
Company Presentations
Please Select ...
Privately Funded Company (230)
Publicly Traded Company (80)
Advocacy/Non-Profit/Other (29)
Oncology (67)
CNS/Neurological (34)
Other (31)
Multiple Therapeutics (30)
Platform for Therapeutics (19)
Tools/Drug Development Support Tech (17)
Gene/Cell Therapy (15)
Contract Research Organization (12)
Infectious Diseases (11)
Digital Health (11)
Orphan/Rare Diseases (9)
Contract Manufacturing Organization (9)
Regenerative Medicine (8)
Metabolic Diseases (8)
Ophthalmology (7)
Diagnostics (6)
Gastrointestinal (5)
Inflammation (5)
Medical Devices (5)
Dermatology (4)
Immunology (4)
Multiline Global Biopharma (4)
Non-Profit/Patient Advocacy Group (4)
Cardiovascular (4)
Pain Management (3)
COVID-19 (2)
Industrial & Environmental (2)
Reproductive/Sexual Health (2)
Respiratory (2)
Food & Agriculture (1)
Renewable Chemicals (1)
Pre-Clinical (92)
Other/Not Applicable (67)
Phase I (33)
Phase II (33)
Multiple Products in Market (33)
Phase III (28)
Discovery (13)
NDA Preparation / In Review (9)
Phase IV (1)
Apply
Reset
×
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Wooyeol Baek
CEO, PLCOSKIN INC.
PLCOSKIN Inc.
Seoul, Korea, Republic of
Christopher Bahl, MS, PhD
HEAD OF PROTEIN DESIGN, INSTITUTE FOR PROTEIN INNOVATION
Institute for Protein Innovation
Boston, Massachusetts, United States
Rebecca Baker, PhD
DIRECTOR, HELPING TO END ADDICTION LONG-TERM (HEAL) INITIATIVE, NATIONAL INSTITUTES OF HEALTH
Disruptive Thinking: What's Next for Pain
United States
Cheryl Baker, PhD
SCIENTIFIC FOUNDER AND CHIEF SCIENTIFIC RESEARCH OFFICER, BIOCURITY PHARMACEUTICALS INC.
BioCurity Pharmaceuticals Inc.
Jupiter, Florida, United States
David Baker
CEO, VALLON PHARMACEUTICALS
Vallon Pharmaceuticals
Philadelphia, Pennsylvania, United States
Sasha Bakhru, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, PEROSPHERE TECHNOLOGIES
Addressing the Unmet Need in Cardiovascular Disease Development
United States
Stéphane Bancel
CHIEF EXECUTIVE OFFICER, MODERNA THERAPEUTICS, INC
A Way Forward: Winning the War on COVID through Vaccines
Cambridge, Massachusetts, United States
Jianxin Bao
CEO, GATEWAY BIOTECHNOLOGY, INC.
Gateway Biotechnology Inc.
Kent, Ohio, United States
Erica Barnes
EXECUTIVE DIRECTOR, MINNESOTA RARE DISEASE ADVISORY COUNCIL
Gene Therapy: The Long Horizon and Broad Challenges
Saint Paul, Minnesota, United States
Jenny Barnett
CEO, MONUMENT TX
Digital Biomarkers: A New Dawn in CNS R&D
Cambridge, United Kingdom
Dror Bashan
CEO, PROTALIX BIOTHERAPEUTICS
Protalix BioTherapeutics
Carmiel, Israel
Ken Batchelor, PhD
CEO, NOVATARG THERAPEUTICS
NovaTarg Therapeutics
Research Triangle Park, North Carolina, United States
Alison Bateman-House, MPH, PhD, MA
ASSISTANT PROFESSOR, DIVISION OF MEDICAL ETHICS, NYU GROSSMAN SCHOOL OF MEDICINE
Bioethics Through the Lens of a Pandemic
New York, New York, United States
Steve Bates
CHIEF EXECUTIVE OFFICER, UK BIOINDUSTRY ASSOCIATION (BIA)
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
London, United Kingdom
Bruce Bauer, PhD
CEO, TAE LIFE SCIENCES
TAE Life Sciences
Foothill Ranch, California, United States
Jake Bauer
CHIEF BUSINESS OFFICER, MYOKARDIA
Precision Medicine Outside Oncology: One Size Does Not Fit All
San Francisco, California, United States
Shannon Baumann
SENIOR DIRECTOR, ACCESS VALUE AND EVIDENCE STRATEGY, BLUEBIRD BIO
Precision financing for Durable/curative Therapies
Susan Baxter, PhD
EXECUTIVE DIRECTOR, CALIFORNIA STATE UNIVERSITY PROGRAM FOR EDUCATION AND RESEARCH IN BIOTECHNOLOGY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
Mandy Bazile
DIRECTOR, GOVERNMENT AFFAIRS, PUBLIC POLICY & REIMBURSEMENT, GENENTECH
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
Yvan Beaudoin
CEO, THORASYS
Thorasys
Montreal, Quebec, Canada
Dirk Beelen
DIRECTOR , HEALTH AND MEDICAL INDUSTRIES SOUTH AUSTRALIA
Health and Medical Industries South Australia
Adelaide, Australia
Sue Behrens, PhD
RATHMANN PROFESSOR IN BIOPROCESSING AND DIRECTOR OF THE AMGEN BIOPROCESSING CENTER, KECK GRADUATE INSTITUTE
Discover/Develop: But How Will you Manufacture Your Therapeutic?
Claremont, California, United States
Piraye Beim
CEO, CELMATIX
Celmatix
New York, New York, United States
Ksenia Belkina
CEO, CARDIOMO CARE, INC.
Cardiomo Care, Inc.
New York, New York, United States
Marc L. Belsky
CHIEF FINANCIAL OFFICER AND SECRETARY, KEZAR LIFE SCIENCES
Federal Economic Recovery Efforts for Small Biotechnology Companies
South San Francisco, California, United States
Rahima Benhabbour
FOUNDER & DIRECTOR, ANELLEO, INC.
Anelleo, Inc.
Chapel Hill, North Carolina, United States
Richard Berenson
CHIEF EXECUTIVE OFFICER, THERMALIN INC.
Thermalin Inc.
Waban, Massachusetts, United States
Fabian Berkemeier
DIRECTOR, VALUE AND ACCESS STRATEGY, IGES INSTITUT GMBH
How will healthcare systems adapt to the Post-COVID-19 World?
Berlin, Germany
Seth Berkley
CEO, GAVI, THE VACCINE ALLIANCE
A Way Forward: Winning the War on COVID through Vaccines
New York, New York, United States
Jeff Berkowitz, JD
CEO AND DIRECTOR, REAL ENDPOINTS
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
New Jersey, United States
Sylvain Berlemont
CEO, KEEN EYE
KEEN EYE
Paris, France
Arnaud Bernaert
HEAD OF HEALTH AND HEALTHCARE, MEMBER OF THE EXECUTIVE COMMITTEE, WORLD ECONOMIC FORUM
Reinventing Partnerships to Deliver Value for Patients & Society
cologny, Switzerland
Brian Berridge, PhD
ASSOCIATE DIRECTOR, NATIONAL TOXICOLOGY PROGRAM; SCIENTIFIC DIRECTOR, DIVISION OF NTP, NIH
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
United States
Gordon Bethwaite
ACTING CEO, NOVAI
Novai
San Diego, California, United States
Ami Bhatt
ASSISTANT PROFESSOR, MEDICINE-HEMATOLOGY AND GENETICS, STANFORD UNIVERSITY
Next Generation Advances in Human Microbiome Research
Stanford, California, United States
Indu Bhushan
CEO AYUSHMAN BHARAT & NATIONAL HEALTH AUTHORITY, GOVERNMENT OF INDIA
The Lure of Universal Healthcare ! What India is doing in Healthcare
New Delhi, India
Barbara Bierer, MD
FACULTY DIRECTOR, MULTI-REGIONAL CLINICAL TRIALS CENTER OF BRIGHAM AND WOMEN'S HOSPITAL AND HARVARD
Including the Patient Voice to Advance Diversity and Support Clear Communications
Cambridge, Massachusetts, United States
Igor Bilinsky
CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS
Oncternal Therapeutics
San Diego, California, United States
Louise Binder
HEALTH POLICY CONSULTANT, SAVE YOUR SKIN FOUNDATION
Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals
Paul Biondi
EXECUTIVE PARTNER, FLAGSHIP PIONEERING
Getting a seat at the table: how can new small companies enter the oncology space?
Princeton, New Jersey, United States
Lars Birgerson, MD, PhD
PRESIDENT & CEO, ADLAI NORTYE USA INC.
Adlai Nortye USA Inc
North Brunswick, New Jersey, United States
Teresa Bitetti
PRESIDENT, GLOBAL ONCOLOGY, TAKEDA
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
Fritz Bittenbender
SENIOR VICE PRESIDENT, GOVERNMENT AFFAIRS, GENENTECH, A MEMBER OF THE ROCHE GROUP
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Washington, United States
Clare Blain
CEO, LIFE SCIENCES QUEENSLAND LIMITED
Queensland, Australia - Global Innovation Hub
Brisbane, Australia
Leah Bloom, PhD
SENIOR VICE PRESIDENT, EXTERNAL INNOVATION AND STRATEGIC ALLIANCES, AVEXIS, A NOVARTIS COMPANY
AveXis, Inc., a Novartis Company
Bannockburn, Illinois, United States
Vincent Blouin, BSc, MBA
CHIEF MARKETING OFFICER, RASPBERRY SCIENTIFIC INC.
Raspberry Scientific Inc.
Magog, Quebec, Canada
Ken Blount, PhD
CHIEF SCIENTIFIC OFFICER, REBIOTIX
Keys to the Cure: Will the Microbiome Live Up to the Hype?
United States
Jeffrey Blue
DIRECTOR OF VACCINE DRUG PRODUCT DEVELOPMENT AND NEW TECHNOLOGIES, MERCK & CO.
Beyond the Needle: Novel Approaches to Vaccine Delivery
Jeffrey Bockman, PhD
EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)
Future of IO Checkpoint Combinations
United States
Sierra Bodor, BS
PUBLIC HEALTH PROGRAM MANAGER, HEPATITIS B FOUNDATION
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
Doylestown, Pennsylvania, United States
Natasha Bonhomme
CHIEF STRATEGY OFFICER, GENETIC ALLIANCE
Next Generation Orphan Drug Incentives
Washington, United States
Aarash Bordbar, PhD
CO-FOUNDER & CTO, SINOPIA BIOSCIENCES, INC.
Sinopia Biosciences, Inc.
San Diego, California, United States
Christophe Bourdon
VICE PRESIDENT AND GENERAL MANGER, ONCOLOGY (US OPERATIONS), AMGEN INC.
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
Vienna, Austria
Terry Bowlin
PRESIDENT & CEO, MICROBIOTIX, INC.
Microbiotix, Inc.
Worcester, Massachusetts, United States
Matt Bradley, PhD
CHAIRMAN, PRESIDENT, FOUNDER, SAJE PHARMA, LLC
SAJE Pharma, LLC
Kalispell, Montana, United States
Kerrie Brady, Bpharm, MBA, MSc
CO-FOUNDER AND FORMER CBO CENTREXION
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
United States
Kimberly Brandt
PRINCIPAL DEPUTY ADMINISTRATOR FOR POLICY & OPERATIONS, CENTERS FOR MEDICAID & MEDICARE SERVICES
Disruptive Thinking: What's Next for Pain
Baltimore, Maryland, United States
Joel Braunstein, MBA, MD
CEO, C2N DIAGNOSTICS, LLC
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
St. Louis, Missouri, United States
Graham Brearley
GENERAL MANAGER, MADISON, CATALENT BIOLOGICS
How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships
Isaac Bright
CEO, RUBRYC THERAPEUTICS, INC.
RubrYc Therapeutics, Inc.
San Carlos, California, United States
Alex Brill
RESIDENT FELLOW, AMERICAN ENTERPRISE INSTITUTE
How can the U.S. cultivate a strong and competitive biosimilars market?
Washington, District Of Columbia, United States
Remy Brim, PhD
VICE PRESIDENT REGULATORY POLICY AND STRATEGY, BGR GOVERNMENT AFFAIRS
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Washington, District Of Columbia, United States
Nicholas Brooke
EXECUTIVE DIRECTOR, PATIENT FOCUSED MEDICINES DEVELOPMENT
Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?
Brussels,
Jason Brown, PhD
CHIEF BUSINESS OFFICER, EVEREST MEDICINES
Licensing Clinical-Stage Assets to Greater China
San Diego, California, United States
Nick Brown
NORTH AMERICAN BUSINESS DEVELOPMENT MANAGER, RETROGENIX LIMITED
Retrogenix Limited
Chinley, High Peak, United Kingdom
Shane Brown
DIRECTOR BUSINESS DEVELOPMENT – WESTERN NORTH AMERICA , OLON RICERCA BIOSCIENCE LLC
Olon S.p.A
Concord, Ohio, United States
Ronan Brown
SENIOR VP & HEAD, INTEGRATED GLOBAL COMPLIANCE, IQVIA, IQVIA
IQVIA
San Diego, California, United States
Wilson Bryan, MD
DIRECTOR, OFFICE OF TISSUES AND ADVANCED THERAPIES, FDA
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
White Oak, Maryland, United States
Matt Bryant, PharmD
VP, GLOBAL MEDICAL AFFAIRS, EIGER BIOPHARMACEUTICALS
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
Palo Alto, California, United States
John Bucksath
CHIEF EXECUTIVE OFFICER AND BOARD MEMBER, KCAS, LLC
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
Shawnee Mission, Kansas, United States
Sanjay Budhdeo, MD
BUSINESS DEV. DIRECTOR, OWKIN
Can AI Prevent Epidemics?
Hugues Bultot
CEO, EXOTHERA
Exothera
Brussels, Belgium
TIMOTHY BURLAND, BSc, PhD
DIRECTOR OF BUSINESS DEVELOPMENT, SCARAB GENOMICS LLC
Scarab Genomics
Wisconsin, United States
Stephen Byers
PROFESSOR OF ONCOLOGY, DIRECTOR, GUMC SHARED RESOURCES , DIVINER THERAPEUTICS LLC
Diviner Therapeutics LLC
Washington, District Of Columbia, United States
Jeff Bylund, PhD
APPLICATIONS MANAGER, NIKON INSTRUMENTS
Nikon BioImaging Lab
Melville, New York, United States
Load More